Virginia · Nonprofit
CONQUER CANCER FOUNDATION OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY
CONQUER CANCER FOUNDATION OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (Virginia) receives grants from 177 organizations whose IRS filings report $33,897,168 to it, the largest being THE BREAST CANCER RESEARCH FOUNDATION INC ($12,079,528). 83 of them have funded it in more than one year.
- Revenue FY2024
- $41M
- Funders on record
- 177
- Grants received
- $34M
- Net assets
- $108M
What Conquer Cancer Foundation of the American Society of Clinical Oncology does
Mission
Conquer cancer funds research for every type of cancer to benefit every patient, everywhere. Working in collaboration with a global network of top scientists and clinicians, and leading advocacy and research organizations, conquer cancer draws (continued in schedule o) on the passion and expertise of the cancer professionals who are members of the american society of clinical oncology (asco). Conquer cancer works to help create a world where cancer is prevented or cured and every survivor is healthy.
As stated on its FY2024 Form 990.
Programs
See schedule o:research: research is how we conquer cancer. It means everything, from understanding how cancer impacts certain people to finding groundbreaking new ways to treat cancer. The conquer cancer grants & awards program has been recognizing excellence in clinical research, quality care, and teaching in the field of oncology since 1984, when the program originally began under the purview of asco. Conquer cancer funds the entire spectrum of research activities related to cancer prevention, screening, treatment, and outcomes research in all cancer types, and supports progress by funding cancer researchers at all stages of their careers, enabling oncology's best and brightest to pursue promising research. Conquer cancer and asco have funded more than $191 million to support grants & awards to over 9,300 recipients in 90 countries. Highlights of 2024 research activities and accomplishments include: *advanced clinical research award (acra): $1,350,000 provided three (3) three-year awards to physician-scientists committed to support clinical cancer research with a patient-oriented focus. Awards supported focused on breast cancer research. *career development award (cda):…
$15,850,256 spentof which $11,835,076 as grants$364,257 earned by the program68% of program spendingSee schedule o:professional education: conquer cancer supports the efforts of asco to provide education programs in the us and internationally which promote the vital exchange of ideas and latest developments that lead to world-class care, everywhere. Funds from conquer cancer are used to support asco's scientific and educational programs through both meetings and electronic education offerings. Highlights of the professional educational and scientific programs supported by conquer cancer and presented to the public in 2024 include the following: * asco annual meeting: the asco annual meeting is a global gathering of more than 44,000 participants where oncology professionals connect, collaborate, and inspire. The meeting is known for advancing the oncology field and offers an experience unlike any other, bringing together the best minds to shape the future of cancer care. *gastrointestinal cancers (gi) symposium: this is one of the premier multidisciplinary gi cancer scientific and educational meetings. The symposium offers the latest innovative science, solution-focused strategies, and multidisciplinary approaches in gi cancer treatment, research, and care. *genitourinary cancers…
$6,121,671 spentof which $5,914,045 as grants26% of program spendingSee schedule o:*quality care symposium: this premier meeting focuses on improving the quality, safety, and efficiency of cancer care delivery, bringing together the entire clinical care team to explore the latest advancements in quality improvement through research, education, and discussions. *merit and abstract awards: $294,000 provided two hundred eighty-nine (289) merit awards to promote clinical research by awarding young scientists whose research is addressed in high quality abstracts submitted to asco meetings with an opportunity to present their research at asco scientific meetings and disease specific symposia. $40,000 provided forty (40) abstract awards to the presenting authors of the 40 highest-rated abstracts selected for presentation at the asco breakthrough meeting that focuses on how innovations in technology create both solutions and challenges in patient care and research.
$1,264,857 spentof which $1,046,367 as grants5% of program spending
The 3 programs described on its FY2024 Form 990, listed largest first by expense. Program spending in total: $23,236,784.
The organization over time
Each line starts at 100 in 2017, so what you read is the shape rather than the size: 150 means half as much again as 2017, 50 means half. The number beside each label in the key is where it ended. The shaded band is where the middle 50% of its peers' revenue would sit, given their growth.
Balance sheet
Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2019 to 2020, from $90M to $108M (+20%).
How it's funded, over time
Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.
Government-grant reliance: 2023 2%. Grants only. Government contracts and fees sit inside program revenue.
90% of CONQUER CANCER FOUNDATION OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY’s revenue is contributions — more reliant on donations than three-quarters of its peers (7% for the typical peer).
Surplus & reserves
Operating surplus or deficit each year, and months of liquidity in hand. 1 of the last 8 reported years ran a deficit.
reserve
Leadership and staff
The officers, directors, trustees and key employees listed on each return. Joined and no longer listed compare each filing with the year before, matching people by surname and first initial; a year after a gap, or a roster under three people, has no comparison.
Board chair
Howard A Burris Iii Md
Board chair
As listed on its FY2024 Form 990.
The chief executive listed changed between the FY2018 and FY2019, and between the FY2019 and FY2020 filings.
Who funds it, year by year
2017 → 2023: the base broadened from 31 funders to 63 funders, grant income rose $991k → $6.6M.
27 of 177 of your funders are donor-advised or pass-through sponsors (tagged DAF) — 16% of grant dollars received. That money is really individual donors directing a sponsor; the institutions to cultivate are the non-DAF funders.
Left out of every figure on this page: $29M from 2 payers (the payer shares this organization's board, largest American Society of Clinical Oncology Inc); $50k from one payer (the same organization on both sides, largest Conquer Cancer Foundation of the American Society of Clinical Oncology). These are real filings, and they are not money CONQUER CANCER FOUNDATION OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY raised.
From the IRS filings of CONQUER CANCER FOUNDATION OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY’s funders (the co-funder graph). Top 30 of 177 funders by total. Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
How concentrated its funding is
CONQUER CANCER FOUNDATION OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY has a broad base — no single funder exceeds 36% of grant income, and it takes 4 funders to reach half.
the vertical line marks half of all grant income — 4 funders to its left
67% of the income these shares are computed over arrives through pass-through sponsors or from payers whose filings do not say what kind of payment it is. Concentration is still measured over all of it, because the money is real; what it does not support is a claim about how many institutions have chosen to fund CONQUER CANCER FOUNDATION OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY.
Largest funder’s share by year: 2017 35% · 2018 55% · 2019 29% · 2020 45% · 2021 27% · 2022 28% · 2023 26% — diversifying over time.
“Effective funders” = inverse Herfindahl index (1 / Σ shareᵢ²) — the number of equal-sized funders that would give the same concentration. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
How long its funders stay
34% of CONQUER CANCER FOUNDATION OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY's funders are still giving 3 years after their first grant; 47% give in more than one year at all.
Share of funders still giving k years after their first recorded grant, pooled across every acquisition cohort. A funder counts as retained in a year only if it made a grant that year. Measured to FY2023, the last fiscal year that has finished arriving — a funder cannot be counted as lapsed in a year most filers have not reached.
Where its funders are
CONQUER CANCER FOUNDATION OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY draws 100% of its grant income from funders outside Virginia, across 30 states in all.
In-state vs out-of-state, by year
Funder states come from each funder’s own filing. $5.5M arriving through sponsors registered in 20 states is excluded from the map and the split above: a sponsor holds money on a donor’s behalf, so its registered address would place those dollars somewhere no donor need ever have been. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Against its field
CONQUER CANCER FOUNDATION OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY runs a healthier operating margin than three-quarters of the 4,580 health nonprofits its size.
this organization peer median middle 50% of peers· 4,580 health nonprofits $10M–$100M, FY2024
Organizations like CONQUER CANCER FOUNDATION OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY
Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.
In Virginia
Nationally
Read directly from this organization’s own Form 990, as neutral context.
Where the money goes
67% of spending goes to programs.
Governance
Public support
74%
Share of support from the public (Schedule A) — the basis for its public-charity status.
Footprint & structure
Files a return copy in 29 states
Part of a family of 3 related entities
- American Society of Clinical Oncology · exempt
- Asco Association · exempt
- Asco Association Political Action Committee · exempt
Screen this organization
A dated, signed PDF of the compliance screen for CONQUER CANCER FOUNDATION OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.
Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf
Questions and answers
- Who funds CONQUER CANCER FOUNDATION OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY?
- CONQUER CANCER FOUNDATION OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (Virginia) receives grants from 177 organizations whose IRS filings report $33,897,168 to it, the largest being THE BREAST CANCER RESEARCH FOUNDATION INC ($12,079,528). 83 of them have funded it in more than one year.
- How many funders does CONQUER CANCER FOUNDATION OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY have?
- IRS filings report 177 organizations giving $33,897,168 in grants to CONQUER CANCER FOUNDATION OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY, 83 of which have funded it in more than one year.
- Who is the largest funder of CONQUER CANCER FOUNDATION OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY?
- THE BREAST CANCER RESEARCH FOUNDATION INC is the largest funder on record, with $12,079,528 in grants. The full list of funders is on this page.
- How can an organization like CONQUER CANCER FOUNDATION OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY find more funders?
- Start with the funders already giving here, then look at the foundations that back similar organizations in Virginia. The funding by cause and by state pages list the largest funders for a given area and how to approach them.
These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2024 (financials across 2017–2024), and the filings of 177 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 22, 2026. What this page cannot tell you · view filing